Cargando…

Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation

OBJECTIVE: Electronic healthcare databases (EHDs) are useful tools for drug development and safety evaluation but their heterogeneity of structure, validity and access across Europe complicates the conduct of multidatabase studies. In this paper, we provide insight into available EHDs to support reg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pacurariu, Alexandra, Plueschke, Kelly, McGettigan, Patricia, Morales, Daniel R, Slattery, Jim, Vogl, Dagmar, Goedecke, Thomas, Kurz, Xavier, Cave, Alison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129090/ https://www.ncbi.nlm.nih.gov/pubmed/30185579 http://dx.doi.org/10.1136/bmjopen-2018-023090

Ejemplares similares

EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making
por: Plueschke, Kelly, et al.
Publicado: (2018)

Correction to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case–Control Study
por: Morales, Daniel R, et al.
Publicado: (2019)

Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case–Control Study
por: Morales, Daniel R, et al.
Publicado: (2018)

Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population‐based nested case–control studies
por: Morales, Daniel R., et al.
Publicado: (2020)

Measuring the impact of medicines regulatory interventions – Systematic review and methodological considerations
por: Goedecke, Thomas, et al.
Publicado: (2017)

Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments
por: McGettigan, Patricia, et al.
Publicado: (2019)

Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe
por: Jonker, Carla J., et al.
Publicado: (2022)

What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?
por: Januskiene, Justina, et al.
Publicado: (2020)

Collection of Data on Adverse Events Related to Medicinal Products: A Survey Among Registries in the ENCePP Resources Database
por: Plueschke, Kelly, et al.
Publicado: (2022)

Barriers and Opportunities for Use of Patient Registries in Medicines Regulation
por: Olmo, Carla Alonso, et al.
Publicado: (2019)

Different Strategies to Execute Multi‐Database Studies for Medicines Surveillance in Real‐World Setting: A Reflection on the European Model
por: Gini, Rona, et al.
Publicado: (2020)

Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
por: Cave, Alison, et al.
Publicado: (2019)

Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in Children
por: Candore, Gianmario, et al.
Publicado: (2020)

Linking electronic mental healthcare and benefits records in South London: design, procedure and descriptive outcomes
por: Stevelink, Sharon A M, et al.
Publicado: (2023)

Correction: Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation
Publicado: (2018)

Healthcare utilisation and costs for temporomandibular disorders: a descriptive, cross-sectional study
por: Seo, Hyejin, et al.
Publicado: (2020)

Interprofessional training for final year healthcare students: a mixed methods evaluation of the impact on ward staff and students of a two-week placement and of factors affecting sustainability
por: McGettigan, Patricia, et al.
Publicado: (2015)

A review of the international Burn Injury Database (iBID) for England and Wales: descriptive analysis of burn injuries 2003–2011
por: Stylianou, Neophytos, et al.
Publicado: (2015)

Validated methods to identify patients with asthma–COPD overlap in healthcare databases: a systematic review protocol
por: Amegadzie, Joseph Emil, et al.
Publicado: (2019)

Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
por: McGettigan, Suzanne
Publicado: (2014)

The social life of voices: studying the neural bases for the expression and perception of the self and others during spoken communication
por: McGettigan, Carolyn
Publicado: (2015)

A prediction model to estimate completeness of electronic physician claims databases
por: Lix, Lisa M, et al.
Publicado: (2015)

Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: characteristics, healthcare utilisation and expenditures
por: Geurten, Rose J, et al.
Publicado: (2021)

Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?
por: Slattery, Jim, et al.
Publicado: (2020)

Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations
por: Morales, Daniel R., et al.
Publicado: (2018)

Relevance of healthcare reimbursement data to monitor syphilis epidemic: an alternative surveillance through the national health insurance database in France, 2011–2013
por: Ndeikoundam Ngangro, Ndeindo, et al.
Publicado: (2018)

Systematic comparison of Mendelian randomisation studies and randomised controlled trials using electronic databases
por: Sobczyk, Maria K, et al.
Publicado: (2023)

Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice
por: Slattery, Jim, et al.
Publicado: (2022)

Recent trends and future directions for lung cancer mortality in Europe
por: Brennan, P, et al.
Publicado: (2002)

Trends in mortality from Hodgkin's disease in western and eastern Europe
por: Levi, F, et al.
Publicado: (2002)

Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
por: McGettigan, Patricia, et al.
Publicado: (2011)

Amplitude Onsets and Spectral Energy in Perceptual Experience
por: Scott, Sophie, et al.
Publicado: (2012)

Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries
por: McGettigan, Patricia, et al.
Publicado: (2013)

Ability of Primary Care Health Databases to Assess Medicinal Products Discussed by the European Union Pharmacovigilance Risk Assessment Committee
por: Flynn, Robert, et al.
Publicado: (2020)

Preterm birth time trends in Europe: a study of 19 countries
por: Zeitlin, J, et al.
Publicado: (2013)

An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study
por: Li, K, et al.
Publicado: (2015)

Descriptive epidemiology of ependymal tumours in the United States
por: Villano, J L, et al.
Publicado: (2013)

Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study
por: Allemani, Claudia, et al.
Publicado: (2013)

Prioritising action on occupational carcinogens in Europe: a socioeconomic and health impact assessment
por: Cherrie, J W, et al.
Publicado: (2017)

Progress in cancer epidemiology: avoided deaths in Europe over the last three decades
por: La Vecchia, Carlo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gcrm73hoq0rg7oe04k2nkeeb4g